本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

22.44
+0.61002.79%
盤前22.890.4500+2.01%08:08 EDT
成交量:167.19萬
成交額:3,684.20萬
市值:25.42億
市盈率:-6.49
高:22.46
開:21.89
低:21.68
收:21.83
52周最高:34.29
52周最低:13.18
股本:1.13億
流通股本:1.01億
量比:1.32
換手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-3.4579
每股收益(LYR):-3.3245
淨資產收益率:-65.74%
總資產收益率:-30.16%
市淨率:4.51
市盈率(LYR):-6.75

資料載入中...

2024/09/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/10

重要事件披露

Form 8-K - Current report
2024/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]